Rapidly	O
Progressive	O
and	O
Almost	O
Lethal	B:C0032285
Pneumonia	I:C0032285

We	O
herein	O
describe	O
the	O
case	O
of	O
a	O
65	O
-	O
year	O
-	O
old	O
male	B:C0025266
patient	O
who	O
presented	O
with	O
Osler	O
's	O
triad	O
,	O
which	O
is	O
the	O
combination	O
of	O
endocarditis	O
,	O
pneumonia	O
,	O
and	O
meningitis	O
.	O

We	O
herein	O
describe	O
the	O
case	O
of	O
a	O
65	O
-	O
year	O
-	O
old	O
male	O
patient	O
who	O
presented	O
with	O
Osler	O
's	O
triad	O
,	O
which	O
is	O
the	O
combination	O
of	O
endocarditis	B:C0014118
,	O
pneumonia	O
,	O
and	O
meningitis	O
.	O

We	O
herein	O
describe	O
the	O
case	O
of	O
a	O
65	O
-	O
year	O
-	O
old	O
male	O
patient	O
who	O
presented	O
with	O
Osler	O
's	O
triad	O
,	O
which	O
is	O
the	O
combination	O
of	O
endocarditis	O
,	O
pneumonia	B:C0032285
,	O
and	O
meningitis	O
.	O

We	O
herein	O
describe	O
the	O
case	O
of	O
a	O
65	O
-	O
year	O
-	O
old	O
male	O
patient	O
who	O
presented	O
with	O
Osler	O
's	O
triad	O
,	O
which	O
is	O
the	O
combination	O
of	O
endocarditis	O
,	O
pneumonia	O
,	O
and	O
meningitis	B:C0025289
.	O

This	O
report	O
is	O
even	O
more	O
unusual	O
since	O
the	O
pathogen	O
isolated	O
was	O
the	O
invasive	O
and	O
virulent	O
strain	O
of	O
Streptococcus	B:C0522401
pneumoniae	I:C0522401
serotype	I:C0522401
3	I:C0522401
.	O

The	O
clinical	O
entity	O
described	O
is	O
also	O
called	O
Austrian	B:C0039082
syndrome	I:C0039082
.	O

Even	O
though	O
rare	O
in	O
this	O
antibiotic	B:C0003232
era	O
,	O
the	O
syndrome	O
remains	O
one	O
of	O
high	O
morbidity	O
and	O
mortality	O
.	O

Even	O
though	O
rare	O
in	O
this	O
antibiotic	O
era	O
,	O
the	O
syndrome	B:C0039082
remains	O
one	O
of	O
high	O
morbidity	O
and	O
mortality	O
.	O

This	O
particular	O
case	O
is	O
of	O
paramount	O
importance	O
for	O
the	O
clinician	B:C0871685
reader	I:C0871685
.	O

First	O
,	O
it	O
documents	O
the	O
clinical	O
features	O
associated	O
with	O
invasive	B:C1320214
pneumococcal	I:C1320214
disease	I:C1320214
and	O
the	O
Austrian	O
syndrome	I:C0039082
.	O

First	O
,	O
it	O
documents	O
the	O
clinical	O
features	O
associated	O
with	O
invasive	O
pneumococcal	I:C1320214
disease	I:C1320214
and	O
the	O
Austrian	B:C0039082
syndrome	I:C0039082
.	O

Second	O
,	O
and	O
equally	O
important	O
,	O
it	O
highlights	O
why	O
following	O
the	O
Surviving	B:C0162791
Sepsis	I:C0162791
Campaign	I:C0162791
guidelines	I:C0162791
saves	O
lives	O
.	O

For	O
this	O
case	O
,	O
the	O
following	O
steps	O
were	O
taken	O
:	O
1	O
.	O
As	O
a	O
surrogate	O
for	O
perfusion	B:C0031001
,	O
early	O
and	O
aggressive	O
fluid	O
resuscitation	I:C0150238
therapy	I:C0150238
(	O
guided	O
by	O
lactic	O
acid	I:C0202115
levels	I:C0202115
)	O
was	O
instituted	O
;	O
2	O
.	O
also	O
early	O
in	O
the	O
treatment	O
,	O
broad	O
spectrum	O
antibiotics	O
were	O
administered	O
;	O
3	O
.	O
to	O
guide	O
antibiotic	O
therapy	I:C0338237
,	O
microbiological	O
cultures	I:C0430402
were	O
obtained	O
.	O

For	O
this	O
case	O
,	O
the	O
following	O
steps	O
were	O
taken	O
:	O
1	O
.	O
As	O
a	O
surrogate	O
for	O
perfusion	O
,	O
early	O
and	O
aggressive	O
fluid	B:C0150238
resuscitation	I:C0150238
therapy	I:C0150238
(	O
guided	O
by	O
lactic	O
acid	I:C0202115
levels	I:C0202115
)	O
was	O
instituted	O
;	O
2	O
.	O
also	O
early	O
in	O
the	O
treatment	O
,	O
broad	O
spectrum	O
antibiotics	O
were	O
administered	O
;	O
3	O
.	O
to	O
guide	O
antibiotic	O
therapy	I:C0338237
,	O
microbiological	O
cultures	I:C0430402
were	O
obtained	O
.	O

For	O
this	O
case	O
,	O
the	O
following	O
steps	O
were	O
taken	O
:	O
1	O
.	O
As	O
a	O
surrogate	O
for	O
perfusion	O
,	O
early	O
and	O
aggressive	O
fluid	O
resuscitation	I:C0150238
therapy	I:C0150238
(	O
guided	O
by	O
lactic	B:C0202115
acid	I:C0202115
levels	I:C0202115
)	O
was	O
instituted	O
;	O
2	O
.	O
also	O
early	O
in	O
the	O
treatment	O
,	O
broad	O
spectrum	O
antibiotics	O
were	O
administered	O
;	O
3	O
.	O
to	O
guide	O
antibiotic	O
therapy	I:C0338237
,	O
microbiological	O
cultures	I:C0430402
were	O
obtained	O
.	O

For	O
this	O
case	O
,	O
the	O
following	O
steps	O
were	O
taken	O
:	O
1	O
.	O
As	O
a	O
surrogate	O
for	O
perfusion	O
,	O
early	O
and	O
aggressive	O
fluid	O
resuscitation	I:C0150238
therapy	I:C0150238
(	O
guided	O
by	O
lactic	O
acid	I:C0202115
levels	I:C0202115
)	O
was	O
instituted	O
;	O
2	O
.	O
also	O
early	O
in	O
the	O
treatment	O
,	O
broad	O
spectrum	O
antibiotics	B:C0003232
were	O
administered	O
;	O
3	O
.	O
to	O
guide	O
antibiotic	O
therapy	I:C0338237
,	O
microbiological	O
cultures	I:C0430402
were	O
obtained	O
.	O

For	O
this	O
case	O
,	O
the	O
following	O
steps	O
were	O
taken	O
:	O
1	O
.	O
As	O
a	O
surrogate	O
for	O
perfusion	O
,	O
early	O
and	O
aggressive	O
fluid	O
resuscitation	I:C0150238
therapy	I:C0150238
(	O
guided	O
by	O
lactic	O
acid	I:C0202115
levels	I:C0202115
)	O
was	O
instituted	O
;	O
2	O
.	O
also	O
early	O
in	O
the	O
treatment	O
,	O
broad	O
spectrum	O
antibiotics	O
were	O
administered	O
;	O
3	O
.	O
to	O
guide	O
antibiotic	B:C0338237
therapy	I:C0338237
,	O
microbiological	O
cultures	I:C0430402
were	O
obtained	O
.	O

For	O
this	O
case	O
,	O
the	O
following	O
steps	O
were	O
taken	O
:	O
1	O
.	O
As	O
a	O
surrogate	O
for	O
perfusion	O
,	O
early	O
and	O
aggressive	O
fluid	O
resuscitation	I:C0150238
therapy	I:C0150238
(	O
guided	O
by	O
lactic	O
acid	I:C0202115
levels	I:C0202115
)	O
was	O
instituted	O
;	O
2	O
.	O
also	O
early	O
in	O
the	O
treatment	O
,	O
broad	O
spectrum	O
antibiotics	O
were	O
administered	O
;	O
3	O
.	O
to	O
guide	O
antibiotic	O
therapy	I:C0338237
,	O
microbiological	B:C0430402
cultures	I:C0430402
were	O
obtained	O
.	O

The	O
patient	O
subsequently	O
improved	O
and	O
was	O
transferred	B:C0030704
to	O
the	O
internal	O
medicine	I:C1305702
ward	I:C1305702
to	O
complete	O
4	O
weeks	O
of	O
antibiotic	O
therapy	I:C0338237
.	O

The	O
patient	O
subsequently	O
improved	O
and	O
was	O
transferred	O
to	O
the	O
internal	B:C1305702
medicine	I:C1305702
ward	I:C1305702
to	O
complete	O
4	O
weeks	O
of	O
antibiotic	O
therapy	I:C0338237
.	O

The	O
patient	O
subsequently	O
improved	O
and	O
was	O
transferred	O
to	O
the	O
internal	O
medicine	I:C1305702
ward	I:C1305702
to	O
complete	O
4	O
weeks	O
of	O
antibiotic	B:C0338237
therapy	I:C0338237
.	O

